US › Healthcare

Utah Medical Products Inc (UTMD)

US · Healthcare · Medical Instruments & Supplies

$72.23+1.68%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$8.6M

Revenue YoY

-12.1%

Net profit

$2.8M

Profit YoY

+5.9%

EPS

$0.88

Net margin

32.3%

Key statistics

Market cap

$193.8M

P/E

20.4

Forward P/E

13.0

P/B

1.72

Book value

$38.83

EPS (TTM)

$3.34

Dividend yield

0.46%

52-week high

$76.89

52-week low

$52.65

50-day MA

$72.90

200-day MA

$68.07

Beta

0.39

Shareholding

Insiders

7.20%

Institutions

76.92%

Largest institutional holders

Fund	Stake
Brandes Investment Partners & Co	14.97%
BlackRock Inc	6.42%
Dimensional Fund Advisors, Inc.	6.26%
Renaissance Technologies Corp	5.54%
Vanguard Capital Management, LLC	4.24%
Geode Capital Management, LLC	3.40%
Minerva Advisors LLC	2.95%
Hotchkis & Wiley Capital Management LLC	2.69%

Corporate actions

Action	Detail	Date
Dividend	$0.31 / share ex-date Sep 17, 2026 · pay Oct 5, 2026	2026-09-17
Dividend	$0.31 / share ex-date Jun 17, 2026 · pay Jul 3, 2026	2026-06-17
Dividend	$0.31 / share ex-date Mar 17, 2026 · pay Apr 3, 2026	2026-03-17
Dividend	$0.31 / share ex-date Dec 16, 2025 · pay Jan 5, 2026	2025-12-16

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Utah Medical Products Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.